scholarly article | Q13442814 |
P356 | DOI | 10.3109/10428194.2011.631236 |
P698 | PubMed publication ID | 21988665 |
P50 | author | L Jeffrey Medeiros | Q87358453 |
Jorge Romaguera | Q88022461 | ||
Anas Younes | Q91632799 | ||
Michelle A Fanale | Q96200428 | ||
Luis E. Fayad | Q106561774 | ||
Yasuhiro Oki | Q114427964 | ||
Amanda R Copeland | Q114726224 | ||
Silvana de Castro Faria | Q114726255 | ||
P2093 | author name string | Percy Ivy | |
P433 | issue | 5 | |
P304 | page(s) | 990-992 | |
P577 | publication date | 2012-03-13 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma | |
P478 | volume | 53 |
Q41197997 | 17AAG-induced internalisation of HER2-specific Affibody molecules |
Q36162351 | Combination of heat shock protein 90 and focal adhesion kinase inhibitors synergistically inhibits the growth of non-small cell lung cancer cells. |
Q42384507 | Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma |
Q35057071 | Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux |
Q26778944 | Hsp90: A New Player in DNA Repair? |
Q39074963 | No stress--Hsp90 and signal transduction in Leishmania |
Search more.